KRN23 (burosumab)

burosumab · Kyowa Kirin, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KRN23 (burosumab), covering 2019-12-16 to 2019-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH) [Phase 2]